Bank of America
TRAW icon

Bank of America’s Traws Pharma TRAW Stock Holding History

Bank of America’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-113
Closed -$128 – 7007
2025
Q4 		$128 Buy
113
+11
+11% +$24 ﹤0.01% 6779
2025
Q3 		$189 Buy
102
+8
+9% +$13 ﹤0.01% 7745
2025
Q2 		$139 Buy
94
+18
+24% +$29 ﹤0.01% 7913
2025
Q1 		$175 Hold
76
– – ﹤0.01% 7717
2024
Q4 		$675 Sell
76
-2,062
-96% -$11.5K ﹤0.01% 7357
2024
Q3 		$12.6K Buy
2,138
+2,130
+26,625% +$19.4K ﹤0.01% 6847
2024
Q2 		$93 Buy
+8
New +$129 ﹤0.01% 7719
2024
Q1 		– Sell
-27
Closed -$506 – 8254
2023
Q4 		$506 Buy
27
+26
+2,600% +$442 ﹤0.01% 7282
2023
Q3 		$23 Hold
1
– – ﹤0.01% 7563
2023
Q2 		$39 Hold
1
– – ﹤0.01% 7481
2023
Q1 		$24 Sell
1
-1
-50% -$22 ﹤0.01% 7560
2022
Q4 		$36 Buy
2
+1
+100% +$19 ﹤0.01% 7864
2022
Q3 		$0 Hold
1
– – ﹤0.01% 8253
2022
Q2 		$0 Hold
1
– – ﹤0.01% 8456
2022
Q1 		$0 Hold
1
– – ﹤0.01% 8852
2021
Q4 		$0 Sell
1
-16
-94% -$1.29K ﹤0.01% 8708
2021
Q3 		$1K Buy
17
+15
+750% +$1.93K ﹤0.01% 8022
2021
Q2 		$0 Buy
+2
New +$452 ﹤0.01% 8147
2019
Q4 		– Sell
-1
Closed – – 7464
2019
Q3 		$0 Buy
+1
New +$861 ﹤0.01% 7550
2019
Q1 		– Hold
0
– – – 7456
2018
Q4 		– Hold
0
– – – 7423
2017
Q4 		– Hold
0
– – – 7290
2017
Q3 		– Hold
0
– – – 7319
2016
Q4 		– Hold
0
– – – 7358
2016
Q3 		– Hold
0
– – – 7400
2016
Q2 		– Hold
0
– – – 7431
2015
Q4 		– Hold
0
– -$10K – 7508
2015
Q3 		– Hold
0
– – – 6572
2015
Q2 		– Hold
0
– – – 6397
2015
Q1 		– Hold
0
– – – 6092
2014
Q4 		– Hold
0
– – – 6972
2014
Q3 		– Hold
0
– -$139K – 8203
2014
Q2 		– Hold
0
– – – 5855
2014
Q1 		– Hold
0
– – – 8120
2013
Q4 		– Hold
0
– – – 6846

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America's TRAW Position: Q1 2026 in Review

Bank of America sold out of Traws Pharma (TRAW) in Q1 2026, closing a stake of 113 shares — an estimated $128 sold.

Bank of America first reported a position in TRAW in Q3 2019 and held it in 19 quarters. The position peaked at $12.6K in Q3 2024. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Bank of America reported no remaining Traws Pharma position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 113 Traws Pharma shares in Q1 2026, an estimated $128.
  • Bank of America first reported a position in Traws Pharma in Q3 2019 and held it in 19 quarters.
  • Bank of America's Traws Pharma position peaked at $12.6K in Q3 2024.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.